Neither is approved by the FDA as a medicine, dietary supplement, or health product, meaning they cannot legally be sold for human consumption or therapeutic use outside of an approved clinical trial context
The VEGFR2 signaling pathway Vascular Endothelial Growth Factor Receptor 2, or VEGFR2, is a primary regulator of blood vessel formation
TB-500's research strength centers on the cellular side of healing (getting repair cells to the injury)
The kinetic and redox properties of this complex, including tuning of the reduction rate by ternary ligands, suggest that it may provide a missing link in copper trafficking as a precursor of Cu(I) ions, for example, for their acquisition by the CTR1 cellular copper transporter
Precaution: This product is not a medicine and has no effect as a substitute for medicament Children, Pregnant women, Breastfeeding Women, Diabetent women, Breast suitable for consumption.